Tauroursodeoxycholic acid attenuates inorganic phosphate-induced osteoblastic differentiation and mineralization in...

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Ectopic ossification is linked to various diseases, but its underlying molecular mechanisms and therapeutic targets require further elucidation.
• Endoplasmic reticulum (ER) stress is a cellular response implicated in disease pathogenesis, but its role in ectopic ossification is not fully understood.

Purpose of the Study:

• To investigate the involvement of ER stress in ectopic ossification.
• To evaluate the therapeutic potential of the ER stress inhibitor tauroursodeoxycholic acid (TUDCA) for ectopic ossification.

Main Methods:

• An in vitro model using inorganic phosphate (Pi)-induced NIH3T3 fibroblasts was employed to mimic ectopic ossification.
• TUDCA treatment during osteogenic induction assessed effects on osteoblast differentiation and mineralization using assays like ALP activity, Alizarin Red-S staining, and Western blot for ER stress markers.
• Key osteoblastic markers (Runx2, Col1a1, ALP, OCN) and ER stress pathway components (PERK-eIF2α-ATF4) were analyzed.

Main Results:

• Inorganic phosphate induced ER stress in NIH3T3 fibroblasts.
• TUDCA significantly inhibited alkaline phosphatase (ALP) activity and mineral nodule formation in a dose-dependent manner.
• TUDCA treatment led to decreased expression of osteoblastic markers and suppressed the PERK-eIF2α-ATF4 ER stress pathway.

Conclusions:

• ER stress is involved in inorganic phosphate-induced fibroblast mineralization.
• TUDCA inhibits ectopic ossification by suppressing the ER stress response, specifically the PERK-eIF2α-ATF4 pathway.
• TUDCA demonstrates potential as a therapeutic agent for treating diseases associated with ectopic ossification.